United States · 
Who invested in Cocoon Biotech?
Cocoon Biotech's investors include MassChallenge.
201620172018201920202021
$1.8MDebt$385KSeed
United States · Seed startup
Who invested in Cocoon Biotech
Funding summaryUpdated 26 Oct 2026
$2.2Mraised across 2 rounds since 2015, from 2 sources
$1.8MDebt$385KSeed
- Latest round
- Seed, $385KDec 2021
- Biggest round
- $1.8MDebt · Oct 2015
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Debt, $1.8M Oct 2015
- Biggest round
- $1.8M Debt · Oct 2015
- Between rounds
- 6.2 years from the last two
The rounds
- Dec 2021
- Oct 2015Debt$1.8M
No investor was named in the report.
From a historical funding recordSEC filing: $1.8M sold, first sale Oct 2015
Founders and team
From Cocoon Biotech's own website and the SEC filings it signed: 1 founder, 5 on the team.
Ailis Tweed-KentCEO & Founder, Board MemberNamed on its 2021 Form D
- Peter MitchellChief Scientific Officer
- Scott DelisleSenior Scientist
- Annalisa JenkinsBoard Member
- Charles KoppelBoard Member
- Mary ThistleBoard Member
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Cocoon Biotech
How much has Cocoon Biotech raised?
Cocoon Biotech has raised $2.2M across 2 rounds since 2015.
When did Cocoon Biotech last raise?
Cocoon Biotech's most recent round was a Seed of $385K in Dec 2021.
What was Cocoon Biotech's biggest round?
Cocoon Biotech's largest round on record is $1.8M (Debt), in Oct 2015.
Who backed Cocoon Biotech first?
Cocoon Biotech's first round on record, in Dec 2021, was backed by MassChallenge.
What stage is Cocoon Biotech at?
Cocoon Biotech's latest named round is a Seed, in Dec 2021.
Where is Cocoon Biotech based?
Cocoon Biotech is based in the United States.
Companies like Cocoon Biotech
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.